Search Results - "Dagrosa, M.A"

First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome by González, S.J, Bonomi, M.R, Santa Cruz, G.A, Blaumann, H.R, Larrieu, O.A.Calzetta, Menéndez, P, Rebagliati, R.Jiménez, Longhino, J, Feld, D.B, Dagrosa, M.A, Argerich, C, Castiglia, S.G, Batistoni, D.A, Liberman, S.J, Roth, B.M.C

“…A Phase I/II protocol for treating cutaneuos melanomas with BNCT was designed in Argentina by the Comisión Nacional de Energı́a Atómica and the medical center…”
Get full text

Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC) by Perona, M., Majdalani, M.E., Rodríguez, C., Nievas, S., Carpano, M., Rossini, A., Longhino, J.M., Cabrini, R., Pisarev, M.A., Juvenal, G.J., Dagrosa, M.A.

“…The present study analyzed different protocols of administration of boronophenylalanine (BPA) and sodium butyrate (NaB) to increase the BNCT efficacy for…”
Get full text

Corrigendum to “Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2-iodohexadecanal” [Mol. Cell. Endocrinol. 317 (1–2) (2010) 141–147] by Thomasz, L., Oglio, R., Rivandeira, D. Toro, Dagrosa, M.A., Jahn, G., Pignataro, O.P., Sartorio, G., Pisarev, M.A., Juvenal, G.J.

Get full text

Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2-iodohexadecanal by Thomasz, L., Oglio, R., Rivandeira, D. Toro, Dagrosa, M.A., Jahn, G., Piganataro, O.P., Sartorio, G., Pisarev, M.A., Juvenal, G.J.

“…Thyroid autoregulation has been related to intraglandular content of an unknown putative iodocompound. The thyroid is capable of producing different iodolipids…”
Get full text

Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP by Viaggi, M, Dagrosa, M.A, Longhino, J, Blaumann, H, Calzetta, O, Kahl, S.B, Juvenal, G.J, Pisarev, M.A

“…We have shown the selective uptake of borophenylalanine (BPA) by undifferentiated human thyroid cancer (UTC) ARO cells both in vitro and in vivo. Moreover, a…”
Get full text

Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy by Dagrosa, M A, Viaggi, M, Kreimann, E, Farías, S, Garavaglia, R, Agote, M, Cabrini, R L, Dadino, J L, Juvenal, G J, Pisarev, M A

“…Undifferentiated thyroid carcinoma (UTC) lacks an effective treatment. Boron neutron capture therapy (BNCT) is based on the selective uptake of 10B-boronated…”
Get more information

Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC) by Dagrosa, M.A, Viaggi, M, Rebagliati, R.Jimenez, Castillo, V.A, Batistoni, D, Cabrini, R.L, Castiglia, S, Juvenal, G.J, Pisarev, M.A

“…Human undifferentiated thyroid carcinoma (UTC) is a very aggressive tumor which lacks an adequate treatment. The UTC human cell line ARO has a selective uptake…”
Get full text

Influence of nicotinamide on the radiosensitivity of normal and goitrous thyroid in the rat by Agote, M, Viaggi, M, Kreimann, E, Krawiec, L, Dagrosa, Juvenal, G J, Pisarev

“…Radioiodine is used to treat thyroid cancer and hyperthyroidism. In order to reduce radiation hazard to the patient and to people in contact with the patient…”
Get more information